VIVOSIM LABS INC (VIVS) Stock News

NASDAQ:VIVS - US68620A3023 - Common Stock

2.44 USD

+0.57 (+30.48%)

Last: 8/29/2025, 8:00:02 PM

2.38 USD

-0.06 (-2.46%)

Pre-Market: 9/2/2025, 4:48:20 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VIVS Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Benzinga - Mentions: RMTI LIXT NEO CHEK ...

12 Health Care Stocks Moving In Friday's Intraday Session

19 days ago - By: VivoSim Labs, Inc.

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

19 days ago - By: VivoSim Labs, Inc.

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

a month ago - By: Yahoo Finance - Mentions: NIO

Nio Inc. (NIO) umbles 8% as Slow July Deliveries Growth Disappoint

4 months ago - By: VivoSim Labs, Inc.

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

4 months ago - By: VivoSim Labs, Inc.

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

4 months ago - By: VivoSim Labs, Inc.

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

4 months ago - By: VivoSim Labs, Inc.

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

4 months ago - By: VivoSim Labs, Inc. - Mentions: ONVO

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

4 months ago - By: VivoSim Labs, Inc. - Mentions: ONVO

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market